Skip to content

Drug interactions

Elafibranor + Fenofibrate

Severity: Moderate

Elafibranor and Fenofibrate: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs activate PPAR-alpha, so combining them may add to the risk of hepatic injury and muscle toxicity. There is no additional lipid-lowering or other benefit that clearly justifies duplication.

What this interaction means in plain words

Elafibranor and Fenofibrate can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Elafibranor belongs to Gastrointestinal Tract; Fenofibrate belongs to Cardiovascular.

Evidence level: Low

Why it happens

Additive PPAR-alpha agonist pharmacodynamic effects on liver and muscle.

What to do

Avoid concurrent use where possible; if combined, monitor liver tests and creatine kinase and watch for myalgia.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Elafibranor and Fenofibrate, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Elafibranor with Fenofibrate?

MediHelp rates the interaction as moderate. Elafibranor and Fenofibrate can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs activate PPAR-alpha, so combining them may add to the risk of hepatic injury and muscle toxicity. There is no additional lipid-lowering or other benefit that clearly justifies duplication.

How serious is the interaction between Elafibranor and Fenofibrate?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use where possible; if combined, monitor liver tests and creatine kinase and watch for myalgia.

What other medicines interact with Elafibranor?

MediHelp also lists interactions of Elafibranor with, for example, Gemfibrozil, Estradiol, Pioglitazone. The full list is on the Elafibranor page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in